CIK 0001061983 · Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 943291317
- Phone
- (650) 624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Director sold 6,756 shares at $50.00 ($337,800)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 2,150 shares at $48.67 ($104,641)
- 4 Planned sale President & CEO sold 5,000 shares at $48.76 ($243,800)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale EVP Research & Development sold 2,000 shares at $38.31 ($76,620)
- 4 Planned sale President & CEO sold 5,000 shares at $38.42 ($192,100)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale EVP Research & Development sold 2,000 shares at $36.34 ($72,680)
- 4 Planned sale President & CEO sold 5,000 shares at $36.45 ($182,250)
- UPLOAD Other SEC-generated Letter
Page 12 of 127 · 2,534 filings